| _淥͡ԭϏSҸF؛ |
 |
r1000 Ԫ() | aأ |
| ӆ1ǧ | l؛أ | |
| ϼܕrg2019-05-27 13:47:45 | g[215 | |
˾
 |
||
| Iģʽaӹ | ˾ͣ؟ι˾ | |
| ИIWgw | Ҫ͑ȫw | |
 ھԃ  |
||
| ϵ:С () | ֙C:15671591110 |
Ԓ: |
: |
| ]:3074722151@qq.com | ַ:hкɽ^ |
|
˾IaƷ3-(h)-1-(CAPS)2,3,5-۱ϩ}}ĩҺwʽ-4-Ͷ}}̴4-ı飬3,5-Sͪ,5-}}uҴǰc4-ıJ1,4-ᣬ濨fgw Q: _͡ ͬx~: 淥͡/_K͡x;R-2: TERT-BUTYL-(+) 7-[4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-(N-METHYLSULFONYLAMINO) PYRIMIDINE-5-YL]-(3R, 5S)-DIOXANE-(E)-6-HEPTENATE;淥͡s|21;淥͡s| 7;_͡;淥͡;_͡;7-[4-(4-)-6--2-(--)--5-]-3,5-u-6-ϩ ӢQ: Rosuvastatin Ӣͬx~: (3R,5S,E)-7-(4-(4-Fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid;Rosuvastatin Impurity 21;Rosuvastatin Impurity 7;ROSUVASTATIN-D3 SODIUM SALT;7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl-methylsulfonyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid;Rosuvastatin;Rosuvastatin Acid;(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-MethylMethanesulfonaMido)-6-(propan-2-yl)pyriMidin-5-yl]-3,5-dihydroxyhept-6-enoic acid CAS̖: 287714-41-4 ʽ: C22H24D3FN3NaO6S : 481.54 EINECS̖: 689-191-5 Pe: 淥͡-;tˎgw;gw;СƄ;API;Isotopically Labeled Pharmaceutical Reference Standard Molļ: 287714-41-4.mol
|
| չʾϢɕTṩݵ挍ԡʴ_ԺͺϷɰlTؓ؟C֮Ҍ˲Гκ؟ ѣҎُILUhُIPaƷǰձش_JY|aƷ| |
